Lucyna Mastalerz
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease (NCT05797597) | Lucyna Mastalerz | 2022-12-07 |
Track Lucyna Mastalerz automatically
Every clearance here is in the API, with alerts when new ones post.